Preeclampsia and retinopathy of prematurity in preterm births

Pediatrics

Volumn 130, Issue 1, 2012, Pages

  Yu, Xiao Dan ^a   Branch, D Ware ^b   Karumanchi, S Ananth ^c   Zhang, Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Preeclampsia; Preterm births; Retinopathy of prematurity

Indexed keywords

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; NEWBORN; PREECLAMPSIA; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

EID: 84863528584     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3881     Document Type: Article

References (39)

1. Gilbert C, Awan H. Blindness in children. BMJ. 2003;327(7418):760-761 (Pubitemid 37211163)
2. Giannantonio C, Papacci P, Molle F, Lepore D, Gallini F, Romagnoli C. An epidemiological analysis of retinopathy of prematurity over 10 years. J Pediatr Ophthalmol Strabismus. 2008;45(3):162-167 (Pubitemid 351955557)
3. Flynn JT, Bancalari E, Snyder ES, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 1992;326(16):1050-1054
4. Holmström G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity-a population-based study. Acta Ophthalmol Scand. 1998;76(2):204-207 (Pubitemid 28177211)
5. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. a multivariate statistical analysis. Ophthalmologica. 2000;214(2):131-135 (Pubitemid 30179209)
6. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75(1):1-8 (Pubitemid 350266733)
7. Walker JJ. Pre-eclampsia. Lancet. 2000;336(9327):1260-1265
8. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683 (Pubitemid 38364626)
9. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642-649 (Pubitemid 43865232)
10. Grill S, Rusterholz C, Zanetti-Dällenbach R, et al. Potential markers of preeclampsia - a review. Reprod Biol Endocrinol. 2009;7:70
11. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9-23
12. Levine RJ, Lam C, Qian C, et al; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992-1005 (Pubitemid 44343543)
13. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478-487
14. Hirashima C, Ohkuchi A, Takahashi K, et al. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors. Hypertens Res. 2011;34(2):212-217
15. Lutty GA, Chan-Ling T, Phelps DL, et al. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis. 2006;12:532-580 (Pubitemid 43778946)
16. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34(2):169-178 (Pubitemid 40545454)
17. Zayed MA, Uppal A, Hartnett ME. New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2010;51(10):4983-4988
18. Fortes Filho JB, Costa MC, Eckert GU, Santos PG, Silveira RC, Procianoy RS. Maternal preeclampsia protects preterm infants against severe retinopathy of prematurity. J Pediatr. 2011;158(3):372-376
19. Zhang J, Troendle J, Reddy UM, Laughon SK, Branch DW, Burkman R, et al Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol. 2010;203(4): 326.e1-326.e10
20. Mikolajczyk RT, Zhang J, Betran AP, et al. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855-1861
21. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99(1): 159-167
22. Dhaliwal CA, Fleck BW, Wright E, Graham C, McIntosh N. Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age. Arch Dis Child Fetal Neonatal Ed. 2009;94(3):F193-F195
23. Palmer EA, Flynn JT, Hardy RJ, et al; The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98(11):1628-1640
24. Lermann VL, Fortes Filho JB, Procianoy RS. The prevalence of retinopathy of prematurity in very low birth weight newborn infants. J Pediatr (Rio J). 2006;82(1):27-32
25. Choo MM, Martin FJ, Theam LC, U-Teng C. Retinopathy of prematurity in extremely low birth weight infants in Malaysia. J AAPOS. 2009;13(5):446-449
26. Huo DM, Dong FT, Dai RP, Chu J, Yu WH. [Prevalence and risk factors of retinopathy of prematurity]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006;28(4):567-569
27. Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet. 2005;365(9461):785-799
28. Roberts JM, Pearson G, Cutler J, Lindheimer M; NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41(3):437-445 (Pubitemid 36314613)
29. Holmström G, Thomassen P, Broberger U. Maternal risk factors for retinopathy of prematurity-a population-based study. Acta Obstet Gynecol Scand. 1996;75(7):628-635 (Pubitemid 26302258)
30. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92(3):905-909
31. Robbins SG, Conaway JR, Ford BL, Roberto KA, Penn JS. Detection of vascular endothelial growth factor (VEGF) protein in vascular and nonvascular cells of the normal and oxygen-injured rat retina. Growth Factors. 1997;14(4):229-241 (Pubitemid 27472562)
32. Roberts JM, Rajakumar A. Preeclampsia and soluble fms-like tyrosine kinase 1. J Clin Endocrinol Metab. 2009;94(7):2252-2254
33. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGFreceptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92(23):10457-10461
34. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603-615
35. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology. 2004;145(11):4835-4837 (Pubitemid 39551099)
36. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):33-39 (Pubitemid 41265677)
37. Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol. 2007;197(2):176.e1-176.e6
38. Wang CN, Chang SD, Peng HH, et al. Change in amniotic fluid levels of multiple antiangiogenic proteins before development of preeclampsia and intrauterine growth restriction. J Clin Endocrinol Metab. 2010;95(3):1431-1441
39. Yelumalai S, Muniandy S, Zawiah Omar S, Qvist R. Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in Malaysian women. J Clin Biochem Nutr. 2010;47(3):191-197